Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers

Therapeutic innovation in cardiovascular medicine is rapidly overcoming the limitations of conventional strategies, providing more targeted, durable, and multidimensional solutions. Key advances include next-generation lipid-lowering agents such as PCSK9 inhibitors, inclisiran, and bempedoic acid, a...

Полное описание

Библиографические подробности

Главные авторы:	Erica Vetrano, Alfredo Caturano, Davide Nilo, Giovanni Di Lorenzo, Giuseppina Tagliaferri, Alessia Piacevole, Mariarosaria Donnarumma, Ilaria Iadicicco, Sabrina Picco, Simona Maria Moretto, Maria Rocco, Raffaele Galiero, Vincenzo Russo, Raffaele Marfella, Luca Rinaldi, Leonilde Bonfrate, Ferdinando Carlo Sasso
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2025-11-01
Серии:	Pharmaceuticals
Предметы:	cardiovascular therapeutics PCSK9 inhibitors inclisiran SGLT2 inhibitors GLP-1 receptor agonists tirzepatide
Online-ссылка:	https://www.mdpi.com/1424-8247/18/11/1703
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!